Attention Deficit Hyperactivity Disorder

• CLINICAL_TRIALS trial_result · 2021-08-23
  Clinical Trial Update: Safety of SPD465 in Treating Adults With ADHD. [Phase 3]

  Phase 3 trial update on SPD465 (attention-deficit/hyperactivity disorder) assessing safety in adults; study completed.

• CLINICAL_TRIALS trial_result · 2021-07-26
  Clinical Trial Update: PRC-063 Adult Laboratory Classroom Study in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 3]

  Phase 3 trial update for PRC-063 in adults with ADHD; study completed with results posted.

• CLINICAL_TRIALS trial_result · 2021-07-19
  Clinical Trial Update: KP415 Open-Label Safety Study in Children (6-12 Years of Age) With ADHD [Phase 3]

  Open-label safety study in children aged 6-12 with ADHD completed; results posted in 2021.

• CLINICAL_TRIALS trial_result · 2021-07-19
  Clinical Trial Update: A Study of Delayed and Extended Release Formulation of Dextroamphetamine Sulfate (HLD100) in Children With ADHD [Phase 2]

  Phase 2 trial update for a delayed and extended-release formulation of dextroamphetamine sulfate (HLD100) in children with ADHD.

• CLINICAL_TRIALS trial_result · 2021-07-14
  Clinical Trial Update: Prevalence of Lidocaine Ineffectiveness in Adults With and Without ADHD [EARLY_Phase 1]

  Phase 1 clinical trial update investigating the prevalence of lidocaine ineffectiveness in adults with and without ADHD, with results posted…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2021-07-08
  Clinical Trial Update: Evaluation of SPN-812 (Viloxazine Extended-release Capsule) High Dose in Children With ADHD [Phase 3]

  Phase 3 trial evaluating high-dose viloxazine extended-release in children with ADHD has completed.

• CLINICAL_TRIALS trial_result · 2021-07-02
  Clinical Trial Update: Evaluation of SPN-812 (Viloxazine Extended-release Capsule) High Dose in Adolescents With ADHD [Phase 3]

  Phase 3 trial evaluating high-dose viloxazine ER (SPN-812) in adolescents with ADHD has completed with results posted.

• CLINICAL_TRIALS trial_result · 2021-07-02
  Clinical Trial Update: Observational Study to Assess the Frequency of Lidocaine Ineffectiveness in Hard-to-treat ADHD [EARLY_Phase 1]

  An early-phase observational study evaluating lidocaine ineffectiveness in hard-to-treat ADHD has completed with results posted.

• CLINICAL_TRIALS trial_result · 2021-06-30
  Clinical Trial Update: KP415 Classroom Study in Children (6-12 Years of Age) With ADHD [Phase 3]

  A Phase 3 clinical trial in children aged 6-12 with ADHD has completed and posted results.

• CLINICAL_TRIALS trial_result · 2021-06-24
  Clinical Trial Update: Efficacy of Lisdexamfetamine Dimesylate for Promoting Occupational Success in Young Adults With ADHD [Phase 4]

  A Phase 4 trial evaluating lisdexamfetamine dimesylate for promoting occupational success in young adults with ADHD has completed with resul…

• CLINICAL_TRIALS trial_result · 2021-06-18
  Clinical Trial Update: Evaluation of SPN-812 (Viloxazine Extended-release Capsule) Low Dose in Adolescents With ADHD [Phase 3]

  Phase 3 trial evaluating low-dose viloxazine extended-release for ADHD in adolescents has completed; results posted in 2021.

• CLINICAL_TRIALS trial_result · 2021-06-08
  Clinical Trial Update: Safety and Efficacy of ADDERALL XR in the Treatment of Adolescents Aged 13-17 With Attention Deficit Hyperactivity Disorder (ADHD) [Phase 3]

  Phase 3 trial update evaluating safety and efficacy of ADDERALL XR in adolescents with ADHD has completed.

• CLINICAL_TRIALS trial_result · 2021-06-08
  Clinical Trial Update: Analog Classroom Study Comparison of ADDERALL XR With STRATTERA in Children Aged 6-12 With ADHD [Phase 4]

  Phase 4 trial comparing ADDERALL XR with STRATTERA in children with ADHD completed.

• CLINICAL_TRIALS trial_result · 2021-06-03
  Clinical Trial Update: The Safety and Efficacy of SPD465 in Adults With Attention Deficit Hyperactivity Disorder (ADHD) [Phase 2]

  Phase 2 trial update evaluating SPD465 for adults with ADHD has completed.

• CLINICAL_TRIALS trial_result · 2021-06-02
  Clinical Trial Update: Evaluation of SPN-812 (Viloxazine Extended-release Capsule) Low Dose in Children With ADHD [Phase 3]

  Phase 3 trial evaluating low-dose viloxazine extended-release for attention deficit/hyperactivity disorder in children has completed with po…

• CLINICAL_TRIALS trial_result · 2021-05-05
  Clinical Trial Update: A Trial Evaluating the Efficacy, Safety, & Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-deficit/Hyperactivity Disorder [Phase 3]

  Phase 3 trial evaluating centanafadine sustained-release tablets for ADHD has completed with results posted in 2021.

• CLINICAL_TRIALS trial_result · 2021-04-09
  Clinical Trial Update: Treatment of Cannabis Use Disorder Among Adults With Comorbid Attention-Deficit/Hyperactivity Disorder [Phase 2, Phase 3]

  Clinical trial update for treatment of cannabis use disorder in adults with comorbid ADHD; study completed with results posted in 2021.

• CLINICAL_TRIALS trial_result · 2021-04-08
  Clinical Trial Update: CTx-1301 Comparative Bioavailability Study [Phase 1, Phase 2]

  Clinical trial update for CTx-1301 reporting comparative bioavailability in ADHD, completed Phase 1 and Phase 2 with results posted.

• CLINICAL_TRIALS trial_result · 2021-04-06
  Clinical Trial Update: Adjuvant Effects of Vitamin A and Vitamin D Supplementation on Treatment of Children With ADHD [Phase 4]

  Phase 4 trial update investigating adjuvant effects of vitamin A and vitamin D supplementation in children with ADHD.

• CLINICAL_TRIALS trial_result · 2021-03-18
  Clinical Trial Update: Dasotraline Pediatric ADHD Study [Phase 2, Phase 3]

  Clinical trial update for dasotraline in pediatric ADHD shows completion across Phase 2 and Phase 3.

• CLINICAL_TRIALS trial_result · 2021-03-16
  Clinical Trial Update: Clinical and Pharmacogenetic Study of Attention Deficit With Hyperactivity Disorder (ADHD) [Phase 4]

  Phase 4 clinical and pharmacogenetic study of Attention Deficit Hyperactivity Disorder has completed.

• CLINICAL_TRIALS trial_result · 2021-03-05
  Clinical Trial Update: Safety and Tolerability Study of SPD489 in Preschool Children Aged 4-5 Years, Diagnosed With Attention-deficit/Hyperactivity Disorder [Phase 3]

  Phase 3 safety and tolerability study of SPD489 in preschool children with ADHD has completed with posted results.

• CLINICAL_TRIALS trial_result · 2021-02-11
  Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 2]

  Phase 2 trial assessing SPN-810 as adjunctive therapy for impulsive aggression in children with ADHD, completed.

• CLINICAL_TRIALS trial_result · 2021-02-10
  Clinical Trial Update: A Trial Evaluating the Efficacy and Safety of HLD200 in Children With ADHD [Phase 3]

  Phase 3 trial evaluating HLD200 for efficacy and safety in children with ADHD has completed and results posted.

• CLINICAL_TRIALS trial_result · 2021-01-12
  Clinical Trial Update: Large-scale Brain Organization During Cognitive Control in ADHD [Phase 4]

  Phase 4 trial in ADHD investigating large-scale brain organization during cognitive control has completed with results posted in 2021.